These proteins form what is called an apoptotic blockade, meaning that cells cannot undergo apoptosis, even when they experience DNA damage that would normally trigger cell death
This formulation combines Cartalax, TB-500, and BPC-157 into a single research blend, providing researchers with a valuable tool for examining coordinated peptide signaling, pathway convergence, and complementary mechanisms involved in tissue organization and extracellular matrix regulation within controlled laboratory environments
The rationale is straightforward: if BPC-157 signals the repair process and TB-500 enables cells to execute it, combining both may produce complementary effects
Products are not intended for human or animal consumption, diagnostic use, therapeutic use, clinical use, veterinary use, or as food, drugs, cosmetics, dietary supplements, or household products